You searched for

Antineoplastic and immunomodulating agents (ATC category)

Your fellow patients have spoken – hear their voices:

The following results on this page are based on 8773 unique reviews from patients using the DrugStars app. These DrugStars users have given a Medicine Experience and Attitude (MEA) score of 63.0 in the range of -100 to +100 for Antineoplastic and immunomodulating agents (ATC category) To see how the MEA Score is calculated click here.

After the results for product Antineoplastic and immunomodulating agents (ATC category) you can add your voice below. Every voice added gets us closer to be being heard by Payers and Pharma, getting us closer to what we call Patient Powered Pharmaceuticals.

63.0

We asked patients how effective they found this medicine.

(8699 respondents)

Answers

Extremely effective (40%)
Very (37%)
Somewhat (16%)
Slightly (5%)
Very little effective (2%)

We asked patients how bothered they were by side effects with this medicine.

(8773 respondents)

Answers

Not at all bothered (36%)
Slightly (29%)
Somewhat (22%)
Very (10%)
Extremely bothered (3%)

We asked patients how often they took this medication as prescribed.

(8773 respondents)

Answers

All the time (83%)
Most of the time (12%)
Often (3%)
Sometimes (2%)
Never (0%)

We asked patients how difficult they found it to take this medicine as prescribed.

(8772 respondents)

Answers

Not at all difficult (75%)
Slightly (14%)
Somewhat (7%)
Very (2%)
Extremely difficult (1%)

We asked patients how confident they felt about taking this medicine.

(8773 respondents)

Answers

Extremely confident (39%)
Very (33%)
Somewhat (21%)
Slightly (5%)
Not at all confident (2%)

We asked patients how necessary they find this medicine.

(8292 respondents)

Answers

Extremely necessary (64%)
Very (27%)
Somewhat (7%)
Slightly (2%)
Not at all necessary (0%)

We asked patients how often they forget to take this medicine at the right time.

(7286 respondents)

Answers

Never (55%)
Rarely (31%)
Sometimes (10%)
Often (3%)
Almost all the time (1%)

We asked patients to what extent they felt the benefits outweighed any disadvantages of this medicine.

(8181 respondents)

Answers

Extremely (47%)
Large (30%)
Moderate (15%)
Small (4%)
Not at all (4%)

We asked patients how satisfied they were with the information and guidance received along with this medicine.

(8181 respondents)

Answers

Very satisfied (47%)
Satisfied (36%)
Neither dissatisfied nor satisfied (13%)
Dissatisfied (3%)
Very dissatisfied (2%)

Add your voice and help others.

If you feel that the information shown is not representative of how you feel, or you want to join the DrugStars movement, helping other patients like you then you can join DrugStars by either downloading the app and adding your medication experiences. Or you can use our webform here on the site, just click the buttons below.

Every time you review a medication you empower patients!

Popular drug reviews

Review recap

DrugsDisclosed has gathered medical insights from 8773 real-world patients taking Antineoplastic and immunomodulating agents (ATC category). These patients are from different countries, lifestyles and healthcare systems, their unifying characteristic is the medicine they take.

8699 patients who were using Antineoplastic and immunomodulating agents (ATC category) were asked how effective they found their medicine. 77% were very positive about Antineoplastic and immunomodulating agents (ATC category) answering that they were very / extremely effective, however 16% felt Antineoplastic and immunomodulating agents (ATC category) was only somewhat effective. Unfortunately 7% of the patients asked felt Antineoplastic and immunomodulating agents (ATC category) had only a slight or very little effect for them.

We asked 8773 patients taking Antineoplastic and immunomodulating agents (ATC category) just how bothered they were by side effects? 65% of those we asked this too reported feeling they were not at all or only slightly bothered by side effects, yet 22% of patients asked said they felt somewhat bothered from Antineoplastic and immunomodulating agents (ATC category). This leaves 13% of the patients we asked who were using Antineoplastic and immunomodulating agents (ATC category) still felt very or extremely bothered from side effects when they were taking Antineoplastic and immunomodulating agents (ATC category).

We asked 8773 patients taking Antineoplastic and immunomodulating agents (ATC category) how often they took their medicine as prescribed by their doctor? 95% said they never, or only sometimes forget, while 3% often forgot to take their Antineoplastic and immunomodulating agents (ATC category) as prescribed. This leaves 2% who sadly forgot to take their Antineoplastic and immunomodulating agents (ATC category) all the time. Taking medication at the right time is very important for your treatment. Try our free app DrugStars to help you manage your medication.

8772 patients were recently asked just how difficult they found it to take their medicine as prescribed by their doctor? 89% of them found it not at all or only somewhat difficult taking Antineoplastic and immunomodulating agents (ATC category) as prescribed, 7% found taking Antineoplastic and immunomodulating agents (ATC category) very difficult which left 3% who sadly felt it extremely difficult for them. There can be many factors that make taking medication an issue, and these should be discussed with the doctor prescribing them.

In a recent patient survey, we asked 8773 patients how confident they felt about taking Antineoplastic and immunomodulating agents (ATC category)? 72% felt either very or extremely confident when it came to taking Antineoplastic and immunomodulating agents (ATC category). while 21% responded that they were only slightly confident leaving 7% of the patients we asked responded feeling only slightly confident when taking Antineoplastic and immunomodulating agents (ATC category).

When asking 8292 patients how necessary they found taking their medication. 91% said they felt taking Antineoplastic and immunomodulating agents (ATC category) to be very or extremely necessary. 7% said they felt Antineoplastic and immunomodulating agents (ATC category) to be only somewhat necessary for them. Finally 2% of patients taking Antineoplastic and immunomodulating agents (ATC category) found it only slightly or even not at all necessary for them.

We asked 7286 patients using Antineoplastic and immunomodulating agents (ATC category) how often they forgot to take their medication? 86% of reported that they never or rarely forgot to take their medication, while 10% of patients taking Antineoplastic and immunomodulating agents (ATC category) reported sometimes forgetting to take their medication. 4% of patients sadly often or almost all the time forget to take their medication. If you forget your medication, we can recommend using DrugStars to help you remember.

When we asked 8181 patients to what extent they felt that the benefits of their medicine outweighed its disadvantages a group of 77% of them replied that they felt to a large or even extreme extent that the advantages of taking Antineoplastic and immunomodulating agents (ATC category) outweighed any disadvantages. 15% of the patients however felt this to a moderate extent leaving 8% who felt this was true to only a small extent or even felt not at all.

We asked 8181 patients taking Antineoplastic and immunomodulating agents (ATC category) in a recent survey if they were satisfied with the information and guidance they received with their medication. 83% of those asked were very satisfied or satisfied with the information. While, 13% of the patients taking Antineoplastic and immunomodulating agents (ATC category) when asked were neither satisfied nor dissatisfied, leaving 4% of patients feeling either dissatisfied or very dissatisfied when it came to the information and guidance they received with their medication.

NO MEDICAL ADVICE OR RECOMMENDATION

The Service is solely intended as a tool to assist you in getting insights on other patients experience with a specific product.

The Service does not provide you with advice or recommendation of any kind and you should not rely upon this website as the basis for any decision or action and is not intended as and may not be relied upon as or substitute medical advice. You are advised to consult a professional advisor or doctor in the relevant field with respect to the applicability of any specific aspect of the contents, including any kind of medical advice.

The data provided do not represent scientific processed data, and is solely based on individuals subjective review. All reviews is verified with a picture during the review process on the DrugStars app.